(Q45752422)

15 December 2017

review article

1 reference

title

Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure (English)

1 reference

15 December 2017

1 reference

1 reference

2

1 reference

15 December 2017

author name string

M P Busch

series ordinal

1

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

15 December 2017

American Journal of Medicine

published in

1 reference

15 December 2017

volume

102

1 reference

15 December 2017

issue

5B

1 reference

15 December 2017

page(s)

117-24; discussion 125-6

1 reference

15 December 2017

Management of occupational exposures to blood-borne viruses

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

A controlled trial of zidovudine in primary human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Natural history of HIV-1 cell-free viremia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Rapid generation of sequence variation during primary HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Viro-immunological studies in acute HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

HIV-1 genomic RNA diversification following sexual and parenteral virus transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Duration of human immunodeficiency virus infection before detection of antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

HIV and blood transfusions: focus on seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Early detection of antibodies to HIV-1 by third-generation assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Sensitivity of HIV-antibody assays determined by seroconversion panels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Progress towards a vaccine to prevent sexual transmission of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900077-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(97)00077-6

1 reference

15 December 2017

release_qjbojhgegvcy3kflszquu535bq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qjbojhgegvcy3kflszquu535bq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9845513

1 reference

15 December 2017